Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Interventions: Drug: INCB099280 Sponsors: Abramson Cancer Center at Penn Medicine; Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Research | Transplants